Posted On: 05/12/2014 6:40:09 PM
Post# of 63824
$PDLI Revenues Increased 52 Percent. $8.47
choppy consolidation
Website
Net income in the first quarter of 2014 was $72.9 million,
or $0.44 per diluted share, as compared with net income
in the first quarter of 2013 of $53.5 million, or $0.36 per diluted share.
The increase in net income in the first quarter is primarily due
to the increase in royalty revenues.
News Release
recent trades
Stockwatch
Nasdaq
PDL BioPharma Q1 Profit Rises - Quick Facts
5/12/2014 4:12:00 PM - RTT News
PDL BioPharma Announces First Quarter 2014 Financial Results
5/12/2014 4:01:00 PM - PR Newswire
After-Hours Earnings Report for May 12, 2014 : MCK, TRQ, BWC,
RAX, PGH, MNKD, TRAK, CVG, PKY, ARNA, DXPE, PDLI
5/12/2014 2:00:04 PM - NASDAQ.com News
Earnings Reaction History: PDL BioPharma Inc, 100.0%
Follow-Through Indicator, 18.1% Sensitive
5/12/2014 6:24:36 AM - MT Newswires
PDL BioPharma to Present at the Bank of America
Merrill Lynch 2014 Health Care Conference
5/8/2014 7:00:00 AM - PR Newswire
% Buy Opinion (composite)
choppy consolidation
Website
Net income in the first quarter of 2014 was $72.9 million,
or $0.44 per diluted share, as compared with net income
in the first quarter of 2013 of $53.5 million, or $0.36 per diluted share.
The increase in net income in the first quarter is primarily due
to the increase in royalty revenues.
News Release
recent trades
Stockwatch
Nasdaq
PDL BioPharma Q1 Profit Rises - Quick Facts
5/12/2014 4:12:00 PM - RTT News
PDL BioPharma Announces First Quarter 2014 Financial Results
5/12/2014 4:01:00 PM - PR Newswire
After-Hours Earnings Report for May 12, 2014 : MCK, TRQ, BWC,
RAX, PGH, MNKD, TRAK, CVG, PKY, ARNA, DXPE, PDLI
5/12/2014 2:00:04 PM - NASDAQ.com News
Earnings Reaction History: PDL BioPharma Inc, 100.0%
Follow-Through Indicator, 18.1% Sensitive
5/12/2014 6:24:36 AM - MT Newswires
PDL BioPharma to Present at the Bank of America
Merrill Lynch 2014 Health Care Conference
5/8/2014 7:00:00 AM - PR Newswire
% Buy Opinion (composite)
(0)
(0)
